A research program designed to enhance spiritual awareness for persons with a cancer diagnosis is accepting volunteer participants at the Bayview Campus of the Johns Hopkins School of Medicine in Baltimore. The program consists of a brief counseling intervention, including medical screening, rapport-building appointments, two all-day sessions that include psilocybin administration, and appointments to facilitate initial integration and application of insights gained. More detailed information is available at cancer-insight.org
Conducted by Drs. Roland Griffiths, William Richards and colleagues, this program is designed to help cancer patients who are suffering with some degree of psychological distress to become less anxious and depressed, and to become more fully engaged with life again. Psilocybin, the psychoactive ingredient in the "sacred mushrooms" that have been used in religious ceremonies by indigenous people in Mesoamerica for approximately two thousand years, is employed to facilitate the resolution of personal conflicts and to occasion states of consciousness that for some may be indistinguishable from visions and mystical experiences recorded in the history of religions. Psilocybin has not been found to be toxic or addictive, and is considered reasonably safe for persons without a history of serious mental illness, when administered in accordance with the safety guidelines published by the Hopkins researchers. Additional information on safety and the unique contributions this intervention may make to human personal and spiritual well-being, may be found here.
The research is FDA approved and is open to persons between 21 and 70. Confidentiality is maintained for all applicants and participants.